{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:53:51Z","timestamp":1781502831525,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Slowed information processing speed (IPS) is the primary cognitive impairment in people with multiple sclerosis (pwMS). Although it is known to affect memory processes, the relationships between verbal learning (VL), verbal memory (VM) and IPS in different phenotypes of multiple sclerosis (MS) remain underexplored. This bicentric study aimed to investigate in detail IPS, VL, and VM as well as the relationships between these cognitive domains in a large sample of 92 pwMS (61 with early relapsing-remitting MS (pwRRMS), 31 with primary-progressive MS (pwPPMS)) and 61 age-matched healthy controls (HC). Compared with HC, pwPPMS performed significantly worse on all cognitive measures, whereas pwRRMS performed worse than HC only on IPS and VL. Irrespective of phenotype, IPS impairment emerged as the core cognitive deficit in MS, affecting 25% of the RRMS group and 45% of the PPMS group. PwRRMS outperformed pwPPMS in all domains, with the most pronounced differences observed in VL. Isolated VL or VM impairments were rare, as most pwMS with these deficits also had concurrent IPS impairment. PwPPMS had significantly higher rates of IPS and VL impairment than pwRRMS, but not in VM. Regression analyses showed that IPS significantly predicted both VL and VM performance in both MS groups. In HC, IPS was only associated with VL performance,\u00a0hinting at different cognitive mechanisms underlying the performance in this domain. This study provides evidence that pwPPMS experience more pronounced cognitive changes in IPS and VL compared to pwRRMS. It also highlights the pervasive impact of IPS on VL and VM performance in both subtypes, underscoring the importance of IPS-focused interventions in the management of MS-related cognitive dysfunction.<\/jats:p>","DOI":"10.1038\/s41598-025-96181-6","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:29:23Z","timestamp":1744115363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The influence of information processing speed on memory processes in patients with relapsing-remitting and primary progressive multiple sclerosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Carolin","family":"Balloff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Johnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"B\u00f6lte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris-Katharina","family":"Penner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils C.","family":"Landmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"96181_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2017.00643","volume":"8","author":"JA Matias-Guiu","year":"2017","unstructured":"Matias-Guiu, J. A. et al. Functional components of cognitive impairment in multiple sclerosis: A Cross-Sectional investigation. Front. Neurol. 8, 1\u20139. https:\/\/doi.org\/10.3389\/fneur.2017.00643 (2017).","journal-title":"Front. Neurol."},{"key":"96181_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7224\/1537-2073.2017-029","volume":"20","author":"G DiGiuseppe","year":"2018","unstructured":"DiGiuseppe, G., Blair, M., Morrow, S. A. & Short Report Prevalence of cognitive impairment in newly diagnosed Relapsing-Remitting multiple sclerosis. Int. J. MS Care. 20, 153\u2013157. https:\/\/doi.org\/10.7224\/1537-2073.2017-029 (2018).","journal-title":"Int. J. MS Care"},{"key":"96181_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict, R. H. B., Amato, M. P., Deluca, J. & Geurts, J. J. G. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 19, 860\u2013871. https:\/\/doi.org\/10.1016\/S1474-4422(20)30277-5 (2020).","journal-title":"Lancet Neurol."},{"key":"96181_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/13524585211011390","volume":"28","author":"C Wojcik","year":"2022","unstructured":"Wojcik, C. et al. Staging and stratifying cognitive dysfunction in multiple sclerosis. Mult Scler. 28, 463\u2013471. https:\/\/doi.org\/10.1177\/13524585211011390 (2022).","journal-title":"Mult Scler."},{"key":"96181_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/13803390490496641","volume":"26","author":"J Deluca","year":"2004","unstructured":"Deluca, J., Chelune, G. J., Tulsky, D. S., Lengenfelder, J. & Chiaravalloti, N. D. Is speed of processing or working memory the primary information processing deficit in multiple sclerosis? J. Clin. Exp. Neuropsychol. 26, 550\u2013562. https:\/\/doi.org\/10.1080\/13803390490496641 (2004).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"96181_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/13803390701779560","volume":"30","author":"C Forn","year":"2008","unstructured":"Forn, C., Belenguer, A., Parcet-Ibars, M. A. & Avila, C. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the paced auditory serial addition test (PASAT). J. Clin. Exp. Neuropsychol. 30, 789\u2013796. https:\/\/doi.org\/10.1080\/13803390701779560 (2008).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"96181_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.neubiorev.2017.09.005","volume":"83","author":"A Johnen","year":"2017","unstructured":"Johnen, A. et al. Distinct cognitive impairments in different disease courses of multiple sclerosis-A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 83, 568\u2013578. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.09.005 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"96181_CR8","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/S0028-3932(02)00041-6","volume":"40","author":"L Sonneville","year":"2002","unstructured":"Sonneville, L. et al. Information processing characteristics in subtypes of multiple sclerosis. Neurpsychologia 40, 1751\u20131765 (2002).","journal-title":"Neurpsychologia"},{"key":"96181_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1467-9280.1996.tb00366.x","volume":"7","author":"AF Fry","year":"1996","unstructured":"Fry, A. F., Hale, S. P. & Speed Working memory, and fluid intelligence: evidence for a developmental cascade. Psychol. Sci. 7, 237\u2013241. https:\/\/doi.org\/10.1111\/j.1467-9280.1996.tb00366.x (1996).","journal-title":"Psychol. Sci."},{"key":"96181_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0001-6918(94)90003-5","volume":"86","author":"R Kail","year":"1994","unstructured":"Kail, R. & Salthouse, T. A. Processing speed as a mental capacity. Acta. Psychol. 86, 199\u2013225 (1994).","journal-title":"Acta. Psychol."},{"key":"96181_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1037\/0033-295X.103.3.403","volume":"103","author":"TA Salthouse","year":"1996","unstructured":"Salthouse, T. A. The Processing-Speed theory of adult age differences in cognition. Psychol. Rev. 103, 403\u2013428 (1996).","journal-title":"Psychol. Rev."},{"key":"96181_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/13803395.2012.760537","volume":"35","author":"ND Chiaravalloti","year":"2013","unstructured":"Chiaravalloti, N. D., Stojanovic-Radic, J. & Deluca, J. The role of speed versus working memory in predicting learning new information in multiple sclerosis. J. Clin. Exp. Neuropsychol. 35, 180\u2013191. https:\/\/doi.org\/10.1080\/13803395.2012.760537 (2013).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"96181_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/23279095.2020.1804911","volume":"29","author":"Z Kouvatsou","year":"2022","unstructured":"Kouvatsou, Z., Masoura, E., Kiosseoglou, G. & Kimiskidis, V. K. Evaluating the relationship between working memory and information processing speed in multiple sclerosis. Appl. Neuropsychol. Adult. 29, 695\u2013702. https:\/\/doi.org\/10.1080\/23279095.2020.1804911 (2022).","journal-title":"Appl. Neuropsychol. Adult"},{"key":"96181_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/13803395.2010.541427","volume":"33","author":"VM Leavitt","year":"2011","unstructured":"Leavitt, V. M., Lengenfelder, J., Moore, N. B., Chiaravalloti, N. D. & Deluca, J. The relative contributions of processing speed and cognitive load to working memory accuracy in multiple sclerosis. J. Clin. Exp. Neuropsychol. 33, 580\u2013586. https:\/\/doi.org\/10.1080\/13803395.2010.541427 (2011).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"96181_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1017\/S1355617713000155","volume":"19","author":"EM Owens","year":"2013","unstructured":"Owens, E. M., Denney, D. R. & Lynch, S. G. Difficulties in planning among patients with multiple sclerosis: a relative consequence of deficits in information processing speed. J. Int. Neuropsychol. Soc. 19, 613\u2013620. https:\/\/doi.org\/10.1017\/S1355617713000155 (2013).","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"96181_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon, D. W. et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler. 18, 891\u2013898. https:\/\/doi.org\/10.1177\/1352458511431076 (2012).","journal-title":"Mult Scler."},{"key":"96181_CR17","unstructured":"Delis, D. C., Kramer, J. H., Kaplan, E. & Ober, B. A. California Verbal Learning Test (CVLT-II). Second Edition (Pearson Assessment, 2000)."},{"key":"96181_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/13854040903266910","volume":"24","author":"S Stegen","year":"2010","unstructured":"Stegen, S. et al. Validity of the California verbal learning Test-II in multiple sclerosis. Clin. Neuropsychol. 24, 189\u2013202. https:\/\/doi.org\/10.1080\/13854040903266910 (2010).","journal-title":"Clin. Neuropsychol."},{"key":"96181_CR19","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1177\/13524585221088190","volume":"28","author":"ND Chiaravalloti","year":"2022","unstructured":"Chiaravalloti, N. D. et al. The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis. Mult Scler. 28, 1783\u20131792. https:\/\/doi.org\/10.1177\/13524585221088190 (2022).","journal-title":"Mult Scler."},{"key":"96181_CR20","unstructured":"Smith, A. Symbol Digit Modalities Test (SDMT)Western Psychological Services (1982)."},{"key":"96181_CR21","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti, N. D. & Deluca, J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 7, 1139\u20131151 (2008).","journal-title":"Lancet Neurol."},{"key":"96181_CR22","doi-asserted-by":"publisher","unstructured":"Mac\u00edas Islas, M. \u00c1. & Ciampi, E. Assessment and impact of cognitive impairment in multiple sclerosis: an overview. Biomedicines 7. https:\/\/doi.org\/10.3390\/biomedicines7010022 (2019).","DOI":"10.3390\/biomedicines7010022"},{"key":"96181_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jns.2014.05.042","volume":"343","author":"M Fischer","year":"2014","unstructured":"Fischer, M. et al. How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis? J. Neurol. Sci. 343, 91\u201399. https:\/\/doi.org\/10.1016\/j.jns.2014.05.042 (2014).","journal-title":"J. Neurol. Sci."},{"key":"96181_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/1352458516645869","volume":"23","author":"SL Costa","year":"2017","unstructured":"Costa, S. L., Genova, H. M., Deluca, J. & Chiaravalloti, N. D. Information processing speed in multiple sclerosis: past, present, and future. Multiple Scler. J. 23, 772\u2013789. https:\/\/doi.org\/10.1177\/1352458516645869 (2017).","journal-title":"Multiple Scler. J."},{"key":"96181_CR25","unstructured":"Rao, S. M. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis (Medical College of Wisconsin, 1990)."},{"key":"96181_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RH Benedict","year":"2017","unstructured":"Benedict, R. H. et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 23, 721\u2013733. https:\/\/doi.org\/10.1177\/1352458517690821 (2017).","journal-title":"Mult Scler."},{"key":"96181_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00115-004-1729-0","volume":"75","author":"P Scherer","year":"2004","unstructured":"Scherer, P., Baum, K., Bauer, H., G\u00f6hler, H. & Miltenburger, C. Normierung der brief repeatable battery of neuropsychological tests (BRB-N) f\u00fcr Den deutschsprachigen raum Anwendung Bei schubf\u00f6rmig remittierenden und Sekund\u00e4r progredienten Multiple-Sklerose-Patienten. Der Nervenarzt. 75, 984\u2013990. https:\/\/doi.org\/10.1007\/s00115-004-1729-0 (2004).","journal-title":"Der Nervenarzt"},{"key":"96181_CR28","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s00415-018-9034-1","volume":"265","author":"M Filser","year":"2018","unstructured":"Filser, M. et al. The brief international cognitive assessment in multiple sclerosis (BICAMS): results from the German validation study. J. Neurol. 265, 2587\u20132593. https:\/\/doi.org\/10.1007\/s00415-018-9034-1 (2018).","journal-title":"J. Neurol."},{"key":"96181_CR29","unstructured":"Helmstaedter, C., Lendt, M. & Lux, S. Verbaler Lern-und Merkf\u00e4higkeitstest: VLMT. Manual (Beltz-Test, 2001)."},{"key":"96181_CR30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"IK Penner","year":"2009","unstructured":"Penner, I. K. et al. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 15, 1509\u20131517. https:\/\/doi.org\/10.1177\/1352458509348519 (2009).","journal-title":"Mult Scler."},{"key":"96181_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00115-005-1990-x","volume":"77","author":"P Flachenecker","year":"2006","unstructured":"Flachenecker, P. et al. Fatigue Bei multipler sklerose. Entwicklung und validierung des W\u00fcrzburger Ersch\u00f6pfungsinventars Bei MS. Der Nervenarzt. 77, 165\u2013166. https:\/\/doi.org\/10.1007\/s00115-005-1990-x (2006). 168\u2009\u2013\u200970, 172-4.","journal-title":"Der Nervenarzt"},{"key":"96181_CR32","unstructured":"Herrmann-Lingen, C., Buss, U. & Snaith, R. P. Hospital Anxiety and Depression Scale - Deutsche Version (HADS-D). Manual (H.Huber, 2011)."},{"key":"96181_CR33","unstructured":"Hautzinger, M., Keller, F. & K\u00fchner, C. BDI-II. Beck-Depressions-Inventar 2nd edn (Pearson Assessment, 2009)."},{"key":"96181_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3389\/fneur.2019.00581","volume":"10","author":"C Oreja-Guevara","year":"2019","unstructured":"Oreja-Guevara, C. et al. Cognitive dysfunctions and assessments in multiple sclerosis. Front. Neurol. 10, 581. https:\/\/doi.org\/10.3389\/fneur.2019.00581 (2019).","journal-title":"Front. Neurol."},{"key":"96181_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7224\/1537-2073.2013-013","volume":"16","author":"TM Watson","year":"2014","unstructured":"Watson, T. M., Ford, E., Worthington, E. & Lincoln, N. B. Validation of mood measures for people with multiple sclerosis. Int. J. MS Care. 16, 105\u2013109. https:\/\/doi.org\/10.7224\/1537-2073.2013-013 (2014).","journal-title":"Int. J. MS Care"},{"key":"96181_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1467-8721.2008.00547.x","volume":"17","author":"A Herlitz","year":"2008","unstructured":"Herlitz, A. & Rehnman, J. Sex differences in episodic memory. Curr. Dir. Psychol. Sci. 17, 52\u201356. https:\/\/doi.org\/10.1111\/j.1467-8721.2008.00547.x (2008).","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"96181_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1037\/0033-2909.117.2.285","volume":"117","author":"DB Burt","year":"1995","unstructured":"Burt, D. B., Zembar, M. J. & Niederehe, G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol. Bull. 117, 285\u2013305. https:\/\/doi.org\/10.1037\/0033-2909.117.2.285 (1995).","journal-title":"Psychol. Bull."},{"key":"96181_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1037\/0090-5550.49.1.62","volume":"49","author":"J Deluca","year":"2004","unstructured":"Deluca, J. et al. The nature of memory impairment in chronic fatigue syndrome. Rehabil. Psychol. 49, 62\u201370. https:\/\/doi.org\/10.1037\/0090-5550.49.1.62 (2004).","journal-title":"Rehabil. Psychol."},{"key":"96181_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1037\/0882-7974.7.1.72","volume":"7","author":"RL West","year":"1992","unstructured":"West, R. L., Crook, T. H. & Barron, K. L. Everyday memory performance across the life span: effects of age and noncognitive individual differences. Psychol. Aging. 7, 72\u201382.  (1992).","journal-title":"Psychol. Aging"},{"key":"96181_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann, T. et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 22, 78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7 (2023).","journal-title":"Lancet Neurol."},{"key":"96181_CR41","doi-asserted-by":"publisher","unstructured":"Sandi, D., Fricska-Nagy, Z., Bencsik, K. & V\u00e9csei, L. Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players. Molecules (Basel, Switzerland) 26.   https:\/\/doi.org\/10.3390\/molecules26113423 (2021).","DOI":"10.3390\/molecules26113423"},{"key":"96181_CR42","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s11845-020-02377-2","volume":"190","author":"P Yigit","year":"2021","unstructured":"Yigit, P., Acikgoz, A., Mehdiyev, Z., Dayi, A. & Ozakbas, S. The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis. Ir. J. Med. Sci. 190, 1129\u20131136. https:\/\/doi.org\/10.1007\/s11845-020-02377-2 (2021).","journal-title":"Ir. J. Med. Sci."},{"key":"96181_CR43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamaneurol.2020.4920","volume":"78","author":"E Meo","year":"2021","unstructured":"Meo, E. et al. Identifying the distinct cognitive phenotypes in multiple sclerosis. JAMA Neurol. 78, 414\u2013425. https:\/\/doi.org\/10.1001\/jamaneurol.2020.4920 (2021).","journal-title":"JAMA Neurol."},{"key":"96181_CR44","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00415-024-12227-1","volume":"271","author":"M van Dam","year":"2024","unstructured":"van Dam, M. et al. Identifying and Understanding cognitive profiles in multiple sclerosis: a role for visuospatial memory functioning. J. Neurol. 271, 2195\u20132206. https:\/\/doi.org\/10.1007\/s00415-024-12227-1 (2024).","journal-title":"J. Neurol."},{"key":"96181_CR45","first-page":"NP24","volume":"25","author":"M Mansincal","year":"2019","unstructured":"Mansincal, M., Degraeve, B., Hautecoer, P. & Lenne, B. Relationship between information processing speed and episodic memory in MS. Multiple Scler. J. 25, NP24\u2013NP24 (2019).","journal-title":"Multiple Scler. J."},{"key":"96181_CR46","doi-asserted-by":"publisher","unstructured":"Weinstock, Z. L. & Benedict, R. H. B. Cognitive Relapse in Multiple Sclerosis: New Findings and Directions for Future Research. NeuroSci 3, 510\u2013520. https:\/\/doi.org\/10.3390\/neurosci3030036 (2022).","DOI":"10.3390\/neurosci3030036"},{"key":"96181_CR47","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1076\/jcen.25.4.489.13878","volume":"25","author":"ND Chiaravalloti","year":"2003","unstructured":"Chiaravalloti, N. D., Christodoulou, C., Demaree, H. A. & Deluca, J. Differentiating simple versus complex processing speed: influence on new learning and memory performance. J. Clin. Exp. Neuropsychol. 25, 489\u2013501. https:\/\/doi.org\/10.1076\/jcen.25.4.489.13878 (2003).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"96181_CR48","unstructured":"Benedict, R. H. B. Brief Visuospatial Memory Test - Revised: Professional Manual (Psychological Assessment Resources, Inc., 1997)."},{"key":"96181_CR49","unstructured":"Waskowiak, P. et al. The Impact of Information Processing Speed Deficits on Visuospatial Memory in Multiple Sclerosis: Preliminary Results. Poster presentation at the 9th joint ECTRIMS-ACTRIMS Meeting, Oct 11 (2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96181-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:29:26Z","timestamp":1744115366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96181-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96181"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96181-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CB has received research funding from the German MS Society (DMSG), speaker honoraria and travel expenses from Roche, and speaker honoraria from Synaptikon GmbH unrelated to this work. SGM has received honoraria for lecturing and travel expenses for attending meetings from Almirall, Amicus Therapeutics Germany, Bayer Health Care, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, SanofiAventis, Chugai Pharma, QuintilesIMS and Teva, and research funding from the German Ministry for Education and Research (BMBF), the Deutsche Forschungsgemeinschaft, the Else Kr\u00f6ner Fresenius Foundation, the German Academic Exchange Service, the Hertie Foundation, the Interdisciplinary Center for Clinical Studies (IZKF) Muenster, the German Foundation for Neurology, Almirall, Amicus Therapeutics, Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, Merck Serono, Novartis, ONO Pharma, Roche and Teva unrelated to this work. HW receives honoraria for acting as a member of Scientific Advisory Boards from Alexion, Argenx, Biocryst, Bristol Myers Squibb, Cellerys, Galapagos, Janssen, Merck, Novartis, Sandoz-Hexal, uniQure biopharma B.V. Speaker honoraria and travel support from Alexion, AOCN, CEMCAT, AstraZeneca, Biogen, BGP Products Operations GmbH, Bristol Myers Squibb, EPG Health\/Medthority, Genzyme, Kohlhammer, Merck, MS at the Limits, Neurodiem, NMSS, Novartis, Ology, Roche, Sanofi, Springer, Streamed up, TEVA, Uvet, WebMD Global. Prof. Wiendl is acting as a paid consultant for Alexion, Argenx, Argobio, Bristol Myers Squibb, Dianthus, EMD Serono, Fondazione Cariplo, Idorsia, Immunic, Immunovant, INmune Bio_Syneos Health, Janssen, LTS, Lundbeck, Merck, Muna Therapeutics, Myrobalan Therapeutics, Novartis, PSL Group, Red Nucleus, Roche, Samsung, Sangamo, Sanofi, Swiss Multiple Sclerosis Society, Teladochealth, Toleranzia, UCB, Viatris. His research is funded by the Deutsche Forschungsgemeinschaft (DFG), Deutsche Myasthenie Gesellschaft e.V., European Union, Alexion, Amicus Therapeutics Inc., Argenx, Biogen, CSL Behring, F. Hoffmann - La Roche, Genzyme, Merck KgaA, Novartis, Roche, UCB Biopharma all unrelated to this work.AJ has nothing to declare.JB has nothing to declare.I-KP received honoraria for speaking at scientific meetings, serving at scientific advisory boards, and consulting activities from Almirall, Biogen, BMS, Celgene, Sanofi-Genzyme, Janssen, Merck, Novartis, Roche, and Teva unrelated to this work. She received research support from the German MS Society, Celgene, Novartis, Roche, and Teva unrelated to this work. NCL has nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11978"}}